会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • 아젤라산을 이용한 여드름 치료용 화장료 조성물 및 그 제조방법
    • 含有氨基酸的化妆品组合物用于治疗肌酸及其制造方法
    • KR1020080086229A
    • 2008-09-25
    • KR1020070028132
    • 2007-03-22
    • 한국콜마홀딩스 주식회사
    • 김상준강세훈한창규한상근정태화송준식이성종정관영
    • A61K8/34A61K8/97A61Q17/00
    • A61K8/361A61K8/345A61K8/368A61K8/68A61K8/97A61Q19/00Y10S514/859
    • A cosmetic composition containing azelaic acid is provided to improve acne-treating effects of azelaic acid by stabilizing the azelaic acid in cosmetics with low boiling volatile solvent and minimize skin irritation, so that the composition is useful for treating acnes in the skin. A cosmetic composition for treating acnes in the skin contains (a) a lipid-solubilizing part containing 0.1-5.0 parts by weight of biological lipid and 5.0-50.0 parts by weight of polyvalent alcohol, (b) an azelaic acid-solubilizing part containing 0.1-20.0 parts by weight of azelaic acid and 10.0-70.0 parts by weight of volatile alcohol, and (c) a plant extract aqueous phase part containing 1.0-10.0 parts by weight of purified water, 0.1-2.0 parts by weight of lactic acid and 0.1-10.0 parts by weight of plant extract selected from grapefruit skin extract, Portulaca oleracea L. extract, aloe extract, Glycyrrhiza uralensis extract, Althaea rosea Cav. extract and kava kava extract.
    • 提供含有壬二酸的化妆品组合物,通过用低沸点挥发性溶剂使化妆品中的壬二酸稳定并使皮肤刺激最小化来改善壬二酸的痤疮治疗效果,使得该组合物可用于治疗皮肤中的痤疮。 用于治疗皮肤中痤疮的化妆品组合物包含(a)含有0.1-5.0重量份生物脂质和5.0-50.0重量份多元醇的脂溶性部分,(b)含有0.1的壬二酸溶解部分 -20.0重量份壬二酸和10.0-70.0重量份挥发性醇,和(c)植物提取物水相部分,含有1.0-10.0重量份纯化水,0.1-2.0重量份乳酸和 0.1-10.0重量份选自葡萄柚皮提取物,马齿苋提取物,芦荟提取物,甘草提取物,玫瑰花蔷薇Cav的植物提取物。 提取物和卡拉卡瓦提取物。
    • 2. 发明授权
    • 항산화효과와 미백효과를 갖는 한방 약재 추출물과 그추출물의 제조방법 및 이를 포함하는 화장료 조성물
    • 具有抗氧化作用和白化作用的方向药物材料提取物,包含方向药物的提取物和化妆品的制造方法
    • KR100785505B1
    • 2007-12-12
    • KR1020060060382
    • 2006-06-30
    • 한국콜마홀딩스 주식회사
    • 박병준강세훈한창규김남향김동걸
    • A61K8/97A61Q19/02
    • A cosmetic composition comprising the extracts of Oriental medicinal herbs is provided to prevent skin damage and aging by inhibiting oxidation, and whiten the skin by inhibiting activity of tyrosinase and melanin biosynthesis in a B16F10 melanoma cell without side effects. A cosmetic composition for inhibiting oxidation and whitening the skin comprises the extracts of Oriental medicinal herbs including 10-30 parts by weight of Eugenia caryophyllata THUNB., 10-30 parts by weight of Bombycis corpus, 10-30 parts by weight of Pharbitis nil Choisy, 10-30 parts by weight of Tribulus terrestris L., 10-30 parts by weight of Bletilla striata Reichb.fil, 10-30 parts by weight of Angelica dahurica BENTH., 1-5 parts by weight of Poria cocos and 1-10 parts by weight of Phaseolus radiatus L., which are prepared by extracting them with a solvent selected from water, ethanol, methanol, butanol, hexane, ethyl acetate, butylene glycol, propylene glycol, dipropylene glycol, methylene chloride and glycerin through heating at 50-100 deg. C for 1-20 hours or dipping at 5-40 deg. C for 1-15 days.
    • 提供包含东方药草提取物的化妆品组合物,以通过抑制氧化来防止皮肤损伤和老化,并且通过抑制B16F10黑素瘤细胞中酪氨酸酶和黑色素生物合成的活性而使皮肤变白,而没有副作用。 用于抑制皮肤氧化和美白的化妆品组合物包括东方药材的提取物,包括10-30重量份的Eugenia caryophyllata THUNB,10-30重量份的Bombycis语料库,10-30重量份的Pharbitis nil Choisy ,10-30重量份的Trib藜,10-30重量份的小菜蛾Reichb.fil,10-30重量份天竺葵,1-5重量份的茯苓和1- 将10份重量的菜豆(Phaseolus radiatus L.)通过在水,乙醇,甲醇,丁醇,己烷,乙酸乙酯,丁二醇,丙二醇,二丙二醇,二氯甲烷和甘油中的溶剂萃取而制备,通过加热 50-100度 在1-20小时或浸渍在5-40度。 C为1-15天。
    • 3. 发明公开
    • 이데베논 나노캡슐을 함유하는 주름개선 화장료 조성물 및이의 제조방법
    • 防皱化妆品组合物包含纳米尺寸的IDEBENONE及其制造方法
    • KR1020070113711A
    • 2007-11-29
    • KR1020060047328
    • 2006-05-26
    • 한국콜마홀딩스 주식회사
    • 정태화강세훈한창규정관영한상근김동걸이성종김상준
    • A61K8/29
    • An anti-wrinkle cosmetic composition comprising an idebenone nano-capsule is provided to improve the wrinkle improving efficiency of idebenone by stabilizing the idebenone with an inner capsule consisting of ceramide, cholesterol, fatty acid, and phospholipid and an outer capsule consisting of an anionic phosphorous compound and a polymer emulsifying agent derived from a natural polysaccharide. An anti-wrinkle cosmetic composition comprises an idebenone nano-capsule consisting of a core portion including 0.01-2.0 wt.% of idebenone and 1.0-15.0 wt.% of an ester-based polar oil; an inner capsule portion including 2.0-20.0 wt.% of a non-polar oil, 2.0-20.0 wt.% of polyol, 0.01-1.5 wt.% of ceramide, 0.01-1.5 wt.% of cholesterol, 0.01-3.0 wt.% of a fatty acid, 0.01-3.0 wt.% of a higher alcohol, and 0.5-6.0 wt.% of phospholipid on the core portion; an outer capsule portion including 0.01-1.0 wt.% of an anionic phosphorous compound and 0.1-5.0 wt.% of a polymer emulsifying agent on the inner capsule portion; and water in the core portion, the inner capsule portion and the outer capsule portion.
    • 提供了包含艾地苯醌纳米胶囊的抗皱化妆品组合物,以通过用由神经酰胺,胆固醇,脂肪酸和磷脂组成的内胶囊和由阴离子性磷组成的外胶囊稳定艾地苯醌来改善艾地苯醌的皱纹改善效率 化合物和衍生自天然多糖的聚合物乳化剂。 抗皱化妆品组合物包含由包含0.01-2.0重量%艾地苯醌和1.0-15.0重量%酯基极性油的核心部分组成的艾地苯醌纳米胶囊; 包含2.0-20.0重量%的非极性油,2.0-20.0重量%的多元醇,0.01-1.5重量%的神经酰胺,0.01-1.5重量%的胆固醇,0.01-3.0重量% %的脂肪酸​​,0.01-3.0重量%的高级醇和0.5-6.0重量%的核心部分上的磷脂; 在胶囊内部包含0.01-1.0重量%的阴离子性磷化合物和0.1-5.0重量%的聚合物乳化剂的外胶囊部分; 芯部的水分,内胶囊部和外胶囊部。
    • 7. 发明公开
    • 코엔자임 큐텐을 포함하는 나노크기의 리포좀 에멀젼을 담지한 실리카 및 그의 제조방법
    • 使用包含COENZYME Q10的纳米脂质体乳液和使用其的化妆品组合物的二氧化硅的合成
    • KR1020080026960A
    • 2008-03-26
    • KR1020060092242
    • 2006-09-22
    • 한국콜마홀딩스 주식회사
    • 한상근한창규정관영정태화
    • A61K8/02A61K8/18B82Y5/00
    • A silica impregnating nanosized liposome emulsion including coenzyme Q10 is provided to stabilize the coenzyme Q10 by preparing a nano-sized liposome emulsion through application of a nano-technique and then impregnating the emulsion with a porous silica, thereby being applied to various cosmetic compositions. A method for preparing a silica impregnating nanosized liposome emulsion including coenzyme Q10 comprises the steps of: (1) 20.0-80.0 parts by weight of a solvent having two hydroxy groups, 1.0-10.0 parts by weight of lecithin, 0.01-4.0 parts by weight of ceramide, 0.01-4.0 parts by weight of cholesterol, 0.005-2.0parts by weight of an oil soluble antioxidizer and 0.5-2.0 parts by weight of glyceryl behenate/eicosadioate and heating it at a temperature of 65-80 deg.C to prepare an oil phase portion; (b) mixing 0.5-25.0 parts by weight of coenzyme Q10, 1.0-40.0 parts by weight of emollient oil, 0.1-10.0 parts by weight of diethyl sebacate and heating it at a temperature of 45-60 deg.C to prepare an active material portion; (c) mixing 0.5-30.0 parts by weight of water and 0.005-1.0 parts by weight of a water soluble antioxidizer and heating it at a temperature 35-55 deg.C to prepare an aqueous phase portion; (d) after putting the active material portion in the oil phase portion with agitating it at the rotation speed of 1,000-2,000 rpm using a conventional agitator, putting the aqueous phase portion therein with agitating at the rotation speed of 1,000-2,000 rpm to form a first concentrated phase; (e) putting the first concentrated phase in a high pressure type emulsifier at a temperature of 45-65 deg.C and emulsifying the concentrated phase with the pressure of 600-1,500 bar one or two time(2) to form a liposome emulsion having a size of 100 nanometers; (f) cooling the liposome emulsion to a temperature of 30-40 deg.C to stabilize it; (g) after mixing 0.1-60 parts by weight of the liposome emulsion with 1-10 parts by weight of tetraethylorthosilicate with agitating at the rotation speed of 1,000-2,000 rpm for 10 minutes, putting an aqueous solution of sodium hydroxide therein and then leaving it for 3-5 hours to generate silica; and (h) isolating the silica from the reaction solution after completion of the silica generation, washing it with water, drying it and then treating it.
    • 提供包含辅酶Q10的二氧化硅浸渍纳米脂质体乳液,通过应用纳米技术制备纳米尺寸的脂质体乳液,然后用多孔二氧化硅浸渍乳液,从而稳定辅酶Q10,从而适用于各种化妆品组合物。 制备包含辅酶Q10的二氧化硅浸渍纳米脂质体乳液的方法包括以下步骤:(1)20.0-80.0重量份具有两个羟基的溶剂,1.0-10.0重量份卵磷脂,0.01-4.0重量份 的神经酰胺,0.01-4.0重量份的胆固醇,0.005-2.0重量份的油溶性抗氧化剂和0.5-2.0重量份的山嵛酸甘油酯/二十碳烷酸甘油酯,并在65-80℃的温度下加热,以制备 油相部分; (b)将0.5-25.0重量份辅酶Q10,1.0-40.0重量份软化油,0.1-10.0重量份癸二酸二乙酯混合,并在45-60℃的温度下加热,以制备活性物质 材料部分 (c)将0.5-30.0重量份的水和0.005-1.0重量份的水溶性抗氧化剂混合,并在35-55℃的温度下加热以制备水相部分; (d)使用常规搅拌器以1,000-2,000rpm的转速将活性物质部分放入油相部分之后,以1,000-2,000rpm的转速搅拌其中的水相部分,形成 第一个集中阶段; (e)将第一浓缩相置于高温型乳化剂中,温度为45-65℃,并在600-1,500巴的压力下对浓缩物进行一次或两次(2)的乳化,以形成具有 尺寸为100纳米; (f)将脂质体乳液冷却至30-40℃的温度以使其稳定; (g)将0.1-60重量份的脂质体乳液与1-10重量份的原硅酸四乙酯混合,并以1,000-2,000rpm的转速搅拌10分钟,将氢氧化钠水溶液放入其中,然后离开 3-5小时生成二氧化硅; 和(h)在二氧化硅生成完成后从反应溶液中分离二氧化硅,用水洗涤,干燥,然后处理。
    • 8. 发明公开
    • 피부유사막을 갖는 비수계 액정상 캡슐기제 조성물 및 이를이용한 화장료 조성물 및 그 제조방법
    • 具有皮肤类似物膜的非水液晶相的包封组合物,其化妆品组合物及其制造方法
    • KR1020080026956A
    • 2008-03-26
    • KR1020060092227
    • 2006-09-22
    • 한국콜마홀딩스 주식회사
    • 강세훈정태화한창규정관영한상근이성종김상준심미희
    • A61K7/48B82Y5/00B82Y40/00
    • An encapsulated capsule composition is provided to promote the stability of active ingredients by encapsulating the same into a highly packed lamella-type non-aqueous liquid crystalline phase and increase the miscibility with skin by the liquid crystalline phase having a similar structure and composition to intercellular lipids of a skin keratinous layer. An encapsulated composition of a non-water liquid crystalline phase with a skin analogue membrane comprises: a liquid crystalline lipid portion including 10.0-60.0 parts by weight of a water-soluble polar solvent except water, 0.1-10.0 parts by weight of ceramide, 0.05-5.0 parts by weight of cholesterol, 1.0-40.0 parts by weight of phospholipid, and 0.5-7.0 parts by weight of a C16-22 higher alcohol; an oil soluble active material portion including 0.5-20.0 parts by weight of oil, 0.1-10.0 parts by weight of an oil soluble active ingredient, and 0.01-0.5 parts by weight of an oil soluble antioxidizer; and a water-soluble active material portion including 3.0-30.0 parts by weight of a water-soluble polar solvent except water and 0.1-10.0 parts by weight of a water-soluble active ingredient. A method for preparing the encapsulated composition comprises the steps of: (a) preparing the liquid crystalline lipid portion; (b) cooling the temperature of the liquid crystalline lipid portion down to 55-65 deg.C; (c) preparing the oil-soluble active material portion; (d) preparing the water-soluble active material portion; (e) after putting the oil-soluble active material portion in the liquid crystalline lipid portion at a temperature of 55-65 deg.C, agitating it with a conventional agitator to encapsulate a hydrophobic region of the liquid crystalline lipid portion with the oil-soluble active material; (f) after putting the water-soluble active material portion in the first liquid crystalline portion obtained from the step(e) at a temperature of 55-65 deg.C, agitating it with a conventional agitator to encapsulate a hydrophilic region of the liquid crystalline lipid portion with the water-soluble active material; and (g) solidifying lipid chains by cooling down gradually the second liquid crystalline portion obtained from the step(f) to a temperature of 30-40 deg.C to stabilize the oil-soluble and water-soluble active ingredients in a non-water liquid crystalline multi-layer. Further, the phospholipid is selected from a group consisting of phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol and phosphatidylserine.
    • 提供了一种胶囊化胶囊组合物,以通过将活性成分包封在高度包装的薄层型非水性液晶相中以提高活性成分的稳定性,并通过具有与细胞间脂质相似的结构和组成的液晶相增加与皮肤的混溶性 的皮肤角质层。 具有皮肤类似物膜的非水液晶相的包封组合物包括:液晶脂质部分,其包含10.0-60.0重量份除水以外的水溶性极性溶剂,0.1-10.0重量份的神经酰胺,0.05 -5.0重量份胆固醇,1.0-40.0重量份磷脂和0.5-7.0重量份C16-22高级醇; 包含0.5-20.0重量份油,0.1-10.0重量份油溶性活性成分和0.01-0.5重量份油溶性抗氧化剂的油溶性活性物质部分; 和水溶性活性物质部分,其含有3.0〜30.0重量份除水以外的水溶性极性溶剂和0.1-10.0重量份水溶性活性成分。 制备包封的组合物的方法包括以下步骤:(a)制备液晶脂质部分; (b)将液晶脂质部分的温度降低至55-65℃; (c)制备油溶性活性物质部分; (d)制备水溶性活性物质部分; (e)将油溶性活性物质部分置于液晶脂质部分中的温度为55-65℃后,用常规搅拌器搅拌,将液晶脂质部分的疏水区域与油 - 可溶性活性物质; (f)在将水溶性活性物质部分放入步骤(e)得到的第一液晶部分中,在55-65℃的温度下,用常规的搅拌器搅拌以包封液体的亲水区域 结晶脂质部分与水溶性活性物质; 和(g)通过将从步骤(f)获得的第二液晶部分逐渐冷却至30-40℃的温度来固化脂质链,以将油溶性和水溶性活性成分稳定在非水中 液晶多层。 此外,磷脂选自磷脂酰胆碱,磷脂酰乙醇胺,磷脂酰肌醇和磷脂酰丝氨酸。
    • 9. 发明授权
    • 과량의 친유성 생리활성물질을 함유한 나노 농축 캡슐조성물, 이의 제조방법 및 이를 함유한 화장료 조성물
    • 具有高含量油的可溶性活性物质的纳米α浓缩胶囊组合物,其制备方法和包含其的化妆品组合物
    • KR100778946B1
    • 2007-11-28
    • KR1020050093704
    • 2005-10-06
    • 한국콜마홀딩스 주식회사
    • 정태화강세훈한창규정관영한상근이성종송준식
    • A61K8/19A61Q1/02B82Y5/00
    • 본 발명은 최근 들어 각광을 받고 있는 나노기술을 저비용, 고효율로 손쉽게 적용하고, 아울러 그 적용범위를 기초화장품, 색조화장품 등에까지 다양하게 확대하기 위한 기술로써, 피부를 외부물질로부터 보호하고, 수분손실은 줄여주면서, 약물의 피부 전달을 촉진할 수 있도록 각질의 세포막 및 세포간지질과 유사한 조성을 가지면서 과량의 친유성 생리활성물질을 그 입자크기가 30 내지 80nm로 농축안정화하고, 이를 적용하고자하는 화장료에 원하는 친유성 생리활성물질의 유효량만큼을 투입하여 간단히 교반으로도 피부유사 조성 및 구조를 갖는 80 내지 150nm의 나노 캡슐을 손쉽게 얻을 수 있게 하여 사용감뿐만 아니라 친유성 약물의 경피흡수(Transepidermal absorption of drugs)를 촉진하여 약물이 가지는 효능을 배가시킬수 있는 과량의 친유성 생리활성물질을 함유한 나노 농축 캡슐 조성물 및 그 제조방법에 관한 것으로서, 부틸렌글리콜, 프로필렌글리콜, 글리세린등의 수산기를 2개 이상 가지고 있는 용매에 인지질, 세라마이드, 콜레스테롤, 지방산 및 항산화제를 포함하여 용해시키는 지질농축부를 만들고, 여기에 원하는 친유성 생리활성물질 및 이에 적합한 에몰리언트오일을 포함하는 친유성활성물질부를 투입하여 용해시켜 균일화하고, 여기에 물과 수용성 항산화제를 투입하여 용해시켜 균일화하고, 이를 고압형 유화기로 처리하여 친유성 활성물질을 과량으로 캡슐화하면서도 30 내지 80nm의 나노크기를 갖는 나노농축 캡슐 조성물을 수득하는 데, 상기 캡슐은 다중막(Multi-layer)내부 및 이중층(Bilayer)사이에 과량의 친유성 물질을 농축캡슐화하 는 것으로 이루어지며, 아울러 이를 화장료에 투입하면 친유성 활성물질을 나노화함에 있어서 고비용 및 저효율의 고압형 유화기를 사용하지 않아도 입자의 부피를 줄일 수 있는 기술 개발을 특징으로 한다.
      농축, 나노입자, 친유성 생리활성물질, 세포막 유사체, 수산기, 인지질, 세라마이드, 콜레스테롤
    • 10. 发明公开
    • 과량의 친유성 생리활성물질을 함유한 나노 농축 캡슐조성물, 이의 제조방법 및 이를 함유한 화장료 조성물
    • 具有高含量油溶性活性材料的纳米浓缩胶囊组合物,其制造方法和含有其的化妆品组合物
    • KR1020070038606A
    • 2007-04-11
    • KR1020050093704
    • 2005-10-06
    • 한국콜마홀딩스 주식회사
    • 정태화강세훈한창규정관영한상근이성종송준식
    • A61K8/19A61Q1/02B82Y5/00
    • A61K8/11A61K8/345A61K8/355A61K8/36A61K8/553A61K8/63A61K8/676A61K8/678A61K8/68A61K8/92A61K2800/413
    • 본 발명은 최근 들어 각광을 받고 있는 나노기술을 저비용, 고효율로 손쉽게 적용하고, 아울러 그 적용범위를 기초화장품, 색조화장품 등에까지 다양하게 확대하기 위한 기술로써, 피부를 외부물질로부터 보호하고, 수분손실은 줄여주면서, 약물의 피부 전달을 촉진할 수 있도록 각질의 세포막 및 세포간지질과 유사한 조성을 가지면서 과량의 친유성 생리활성물질을 그 입자크기가 30 내지 80nm로 농축안정화하고, 이를 적용하고자하는 화장료에 원하는 친유성 생리활성물질의 유효량만큼을 투입하여 간단히 교반으로도 피부유사 조성 및 구조를 갖는 80 내지 150nm의 나노 캡슐을 손쉽게 얻을 수 있게 하여 사용감뿐만 아니라 친유성 약물의 경피흡수(Transepidermal absorption of drugs)를 촉진하여 약물이 가지는 효능을 배가시킬수 있는 과량의 친유성 생리활성물질을 함유한 나노 농축 캡슐 조성물 및 그 제조방법에 관한 것으로서, 부틸렌글리콜, 프로필렌글리콜, 글리세린등의 수산기를 2개 이상 가지고 있는 용매에 인지질, 세라마이드, 콜레스테롤, 지방산 및 항산화제를 포함하여 용해시키는 지질농축부를 만들고, 여기에 원하는 친유성 생리활성물질 및 이에 적합한 에몰리언트오일을 포함하는 친유성활성물질부를 투입하여 용해시켜 균일화하고, 여기에 물과 수용성 항산화제를 투입하여 용해시켜 균일화하고, 이를 고압형 유화기로 처리하여 친유성 활성물질을 과량으로 캡슐화하면서도 30 내지 80nm의 나노크기를 갖는 나노농축 캡슐 조성물을 수득하는 데, 상기 캡슐은 다중막(Multi-layer)내부 및 이중층(Bilayer)사이에 과량의 친유성 물질을 농축캡슐화하 는 것으로 이루어지며, 아울러 이를 화장료에 투입하면 친유성 활성물질을 나노화함에 있어서 고비용 및 저효율의 고압형 유화기를 사용하지 않아도 입자의 부피를 줄일 수 있는 기술 개발을 특징으로 한다.
      농축, 나노입자, 친유성 생리활성물질, 세포막 유사체, 수산기, 인지질, 세라마이드, 콜레스테롤